Evidence map›Paper›PMID 36753572›Full record

ArticleJournal of the American Chemical Society2023

Chemical Features of Polyanions Modulate Tau Aggregation and Conformational States.

Kelly M Montgomery, Emma C Carroll, Aye C Thwin, Athena Y Quddus, Paige Hodges, Daniel R Southworth, Jason E Gestwicki

Open access · hybridAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Tau4RD fibril polymorphism is imprinted during early aggregation.bioRxiv : the preprint server for biology · 2025
    Article
  13. DnaJB1 chaperone inhibits tau aggregation by recognizing its N-terminus.bioRxiv : the preprint server for biology · 2025
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Kelly M MontgomeryDepartment of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California 94158, United States.
Emma C CarrollThe Institute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, California 94158, United States.ORCID 0000-0002-6766-4245
Aye C ThwinThe Institute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, California 94158, United States.
Athena Y QuddusThe Institute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, California 94158, United States.
Paige HodgesDepartment of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California 94158, United States.
Daniel R SouthworthThe Institute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, California 94158, United States.ORCID 0000-0001-7108-9389
Jason E GestwickiDepartment of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California 94158, United States.ORCID 0000-0002-6125-3154
University of California, San Francisco · US

Funding

Molecular Chaperones and Small MoleculesR01NS059690 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Jason E Gestwicki · 2008 to 2026
$7.9M
Research Training in Chemistry and Chemical BiologyT32GM145460 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jason E Gestwicki · 2022 to 2026
$3.1M
Molecular recognition of pathological tau fibril conformationsF32AG076281 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CARROLL, EMMA C · 2022 to 2023
$99k
NIA NIH HHS F32 AG076281NIGMS NIH HHS T32 GM145460NINDS NIH HHS R01 NS059690
6 · The paper itself

Abstract

The aggregation of tau into insoluble fibrils is a defining feature of neurodegenerative tauopathies. However, tau has a positive overall charge and is highly soluble; so, polyanions, such as heparin, are typically required to promote its aggregation

Identifiers

PMID36753572
PMCPMC9951223
OpenAlexW4319458990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.